{"id":40895,"date":"2025-09-08T15:23:41","date_gmt":"2025-09-08T07:23:41","guid":{"rendered":"https:\/\/flcube.com\/?p=40895"},"modified":"2025-09-08T15:23:41","modified_gmt":"2025-09-08T07:23:41","slug":"fda-launches-green-list-to-shield-u-s-markets-from-unsafe-glp%e2%80%911-apis","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=40895","title":{"rendered":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs"},"content":{"rendered":"\n<p>The U.S. Food and Drug Administration (FDA) today announced a new <strong>\u201cgreen list\u201d import alert<\/strong> designed to block potentially hazardous <strong>GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs)<\/strong> from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-why-glp-1-matters\">Why GLP\u20111 Matters<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Approved Uses<\/strong> \u2013 Semaglutide and tirzepatide are FDA\u2011approved for type\u202f2 diabetes and, in specific cases, chronic weight management.<\/li>\n\n\n\n<li><strong>Compounding Concerns<\/strong> \u2013 Patients increasingly turn to compounded versions of these drugs, which are <strong>not<\/strong> FDA\u2011approved and have been linked to serious dosing errors, unapproved salt forms, and adverse events\u2014some requiring hospitalization.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-the-green-list-mechanism\">The \u201cGreen List\u201d Mechanism<\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Feature<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Inspected Facilities<\/strong><\/td><td>Only APIs sourced from facilities the FDA has inspected or evaluated for compliance will be admitted.<\/td><\/tr><tr><td><strong>Detention Policy<\/strong><\/td><td>APIs from non\u2011listed sources will be detained <strong>without physical examination<\/strong> pending further review.<\/td><\/tr><tr><td><strong>Ongoing Oversight<\/strong><\/td><td>The FDA will continue to collaborate with state regulators, monitor market activity, and enforce actions against unsafe or fraudulent GLP\u20111 drugs.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-regulatory-context\">Regulatory Context<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The FDA\u2019s decision follows earlier findings that compounded semaglutide and tirzepatide can contain <strong>dosing inaccuracies<\/strong> and <strong>unapproved salt forms<\/strong>, posing significant health risks.<\/li>\n\n\n\n<li>By creating a vetted \u201cgreen list,\u201d the agency seeks to <strong>prevent unsafe compounds<\/strong> from reaching U.S. consumers and to maintain the integrity of the drug supply chain.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-impact-on-stakeholders\">Impact on Stakeholders<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Patients<\/strong> \u2013 Greater assurance that GLP\u20111 medications they receive meet FDA safety standards.<\/li>\n\n\n\n<li><strong>Pharmaceutical Imports<\/strong> \u2013 Companies must ensure their supply chains meet FDA inspection criteria or face detention.<\/li>\n\n\n\n<li><strong>Healthcare Providers<\/strong> \u2013 Must verify the source of GLP\u20111 APIs before prescribing compounded formulations.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert&#8230;<\/p>\n","protected":false},"author":1,"featured_media":40896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[39,86],"class_list":["post-40895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-diabetes","tag-obesity"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert designed to block potentially hazardous GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs) from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=40895\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs\" \/>\n<meta property=\"og:description\" content=\"The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert designed to block potentially hazardous GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs) from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=40895\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-08T07:23:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs\",\"datePublished\":\"2025-09-08T07:23:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895\"},\"wordCount\":278,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0809.webp\",\"keywords\":[\"Diabetes\",\"Obesity\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40895#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=40895\",\"name\":\"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0809.webp\",\"datePublished\":\"2025-09-08T07:23:41+00:00\",\"description\":\"The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert designed to block potentially hazardous GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs) from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40895\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0809.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0809.webp\",\"width\":1080,\"height\":608,\"caption\":\"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40895#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs - Insight, China&#039;s Pharmaceutical Industry","description":"The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert designed to block potentially hazardous GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs) from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=40895","og_locale":"en_US","og_type":"article","og_title":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs","og_description":"The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert designed to block potentially hazardous GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs) from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.","og_url":"https:\/\/flcube.com\/?p=40895","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-08T07:23:41+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=40895#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=40895"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs","datePublished":"2025-09-08T07:23:41+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=40895"},"wordCount":278,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=40895#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp","keywords":["Diabetes","Obesity"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=40895#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=40895","url":"https:\/\/flcube.com\/?p=40895","name":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=40895#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=40895#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp","datePublished":"2025-09-08T07:23:41+00:00","description":"The U.S. Food and Drug Administration (FDA) today announced a new \u201cgreen list\u201d import alert designed to block potentially hazardous GLP\u20111 (glucagon\u2011like peptide\u20111) active pharmaceutical ingredients (APIs) from unverified foreign sources. The measure aims to safeguard patient safety and secure the domestic drug supply chain.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=40895#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=40895"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=40895#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp","width":1080,"height":608,"caption":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=40895#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"FDA Launches \u201cGreen List\u201d to Shield U.S. Markets from Unsafe GLP\u20111 APIs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0809.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40895"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40895\/revisions"}],"predecessor-version":[{"id":40897,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40895\/revisions\/40897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/40896"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}